APGE
Price
$62.97
Change
-$0.13 (-0.21%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
4.31B
Intraday BUY SELL Signals
CLDX
Price
$23.72
Change
-$0.53 (-2.19%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
1.61B
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APGE vs CLDX

Header iconAPGE vs CLDX Comparison
Open Charts APGE vs CLDXBanner chart's image
Apogee Therapeutics
Price$62.97
Change-$0.13 (-0.21%)
Volume$94.09K
Capitalization4.31B
Celldex Therapeutics
Price$23.72
Change-$0.53 (-2.19%)
Volume$28.46K
Capitalization1.61B
APGE vs CLDX Comparison Chart in %
View a ticker or compare two or three
VS
APGE vs. CLDX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and CLDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (APGE: $63.10 vs. CLDX: $24.25)
Brand notoriety: APGE and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 93% vs. CLDX: 77%
Market capitalization -- APGE: $4.31B vs. CLDX: $1.61B
APGE [@Biotechnology] is valued at $4.31B. CLDX’s [@Biotechnology] market capitalization is $1.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while CLDX’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 4 bearish.
  • CLDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both APGE and CLDX are a good buy in the short-term.

Price Growth

APGE (@Biotechnology) experienced а +13.80% price change this week, while CLDX (@Biotechnology) price change was +2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

CLDX is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($4.31B) has a higher market cap than CLDX($1.61B). APGE YTD gains are higher at: 39.294 vs. CLDX (-4.036). CLDX has higher annual earnings (EBITDA): -231.4M vs. APGE (-270.1M). CLDX has more cash in the bank: 630M vs. APGE (505M). CLDX has less debt than APGE: CLDX (3.03M) vs APGE (10.8M). CLDX has higher revenues than APGE: CLDX (5.79M) vs APGE (0).
APGECLDXAPGE / CLDX
Capitalization4.31B1.61B268%
EBITDA-270.1M-231.4M117%
Gain YTD39.294-4.036-973%
P/E RatioN/AN/A-
Revenue05.79M-
Total Cash505M630M80%
Total Debt10.8M3.03M356%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGECLDX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
70%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signal:
Gain/Loss:
CLDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEMAX12.300.08
+0.65%
First Eagle U.S. SMID Cap Opportunity A
IRFRX9.550.05
+0.53%
Cohen & Steers International Realty R
AIECX20.300.07
+0.35%
Invesco EQV International Equity C
HBLVX15.390.03
+0.20%
Hartford Balanced Income R6
BFTHX68.08-0.58
-0.84%
Baron Fifth Avenue Growth Retail

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+0.24%
SYRE - APGE
59%
Loosely correlated
+0.34%
NUVL - APGE
51%
Loosely correlated
+0.91%
IRON - APGE
51%
Loosely correlated
-0.06%
CLDX - APGE
50%
Loosely correlated
-0.49%
ELVN - APGE
50%
Loosely correlated
+3.36%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-0.49%
BEAM - CLDX
55%
Loosely correlated
-2.71%
CRNX - CLDX
53%
Loosely correlated
-0.28%
XNCR - CLDX
52%
Loosely correlated
-3.23%
RVMD - CLDX
52%
Loosely correlated
+2.73%
NUVL - CLDX
52%
Loosely correlated
+0.91%
More